WallStreetZenWallStreetZen

NASDAQ: NKTR
Nektar Therapeutics Earnings & Revenue

NKTR past revenue growth

How has NKTR's revenue growth performed historically?
Company
1.51%
Industry
83.69%
Market
19.3%
NKTR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
NKTR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
NKTR's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

NKTR earnings and revenue history

Current Revenue
$90.2M
Current Earnings
-$175.8M
Current Profit Margin
-195%

NKTR Return on Equity

Current Company
-114.6%
Current Industry
16.9%
Current Market
28.2%
NKTR's Return on Equity (-114.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when NKTR announces earnings.

NKTR Return on Assets

Current Company
-40.6%
Current Industry
3.2%
NKTR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

NKTR Return on Capital Employed

Current Company
-44.11%
Current Industry
-42.5%
NKTR's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NKTR vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
NKTR$90.17M-$144.43M-$175.84M-40.25%N/A
PYXS$16.15M-$54.27M-$57.80MN/AN/A
AKBA$187.23M$7.34M-$43.03M-4.40%N/A
CDXC$83.17M-$1.81M-$3.53M+18.87%N/A
ACRV$0.00-$62.67M-$64.12MN/AN/A

NKTR earnings dates

Next earnings date
Aug 6, 2024

Nektar Therapeutics Earnings & Revenue FAQ

What were NKTR's earnings last quarter?

On Invalid Date, Nektar Therapeutics (NASDAQ: NKTR) reported Q1 2024 earnings per share (EPS) of -$0.19, up 73.97% year over year. Total Nektar Therapeutics earnings for the quarter were -$36.80 million. In the same quarter last year, Nektar Therapeutics's earnings per share (EPS) was -$0.73.

If you're new to stock investing, here's how to buy Nektar Therapeutics stock.

What was NKTR's earnings growth in the past year?

As of Q2 2024, Nektar Therapeutics's earnings has grown year over year. Nektar Therapeutics's earnings in the past year totalled -$175.84 million.

What is NKTR's earnings date?

Nektar Therapeutics's earnings date is Invalid Date. Add NKTR to your watchlist to be reminded of NKTR's next earnings announcement.

What was NKTR's revenue last quarter?

On Invalid Date, Nektar Therapeutics (NASDAQ: NKTR) reported Q1 2024 revenue of $21.64 million up 0.21% year over year. In the same quarter last year, Nektar Therapeutics's revenue was $21.59 million.

What was NKTR's revenue growth in the past year?

As of Q2 2024, Nektar Therapeutics's revenue has grown 1.51% year over year. This is 82.18 percentage points lower than the US Biotechnology industry revenue growth rate of 83.69%. Nektar Therapeutics's revenue in the past year totalled $90.17 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.